Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

2 ML rimabotulinumtoxinB 5000 UNT/ML Injection [Myobloc]

Known as: MYOBLOC 10,000 UNT in 2 ML Injection, Myobloc 10000 UNT per 2 ML Injection, rimabotulinumtoxinB 10000 [USP'U] in 2 mL INTRAMUSCULAR INJECTION, SOLUTION [Myobloc] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
AbstractA systematic pair-wise comparison of all available botulinum toxin serotype A and B treatments for cervical dystonia (CD… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Review
2015
Review
2015
  • D. Dressler
  • Journal of Neural Transmission
  • 2015
  • Corpus ID: 27690046
The global botulinum toxin (BT) market is currently undergoing rapid changes: this may be the time to review the history and the… Expand
2012
2012
ObjectiveTherapeutic botulinum toxins are antigenic proteins with the potential to produce antibodies (Abs). It is, however… Expand
Review
2011
Review
2011
  • A. Pickett
  • Clinical ophthalmology
  • 2011
  • Corpus ID: 6541793
Modern clinical use of botulinum toxin (BoNT) by doctors requires evidence-based facts and data to support their work. In… Expand
  • table 1
Review
2010
Review
2010
  • T. Flynn
  • American journal of clinical dermatology
  • 2010
  • Corpus ID: 39497494
Patient satisfaction with botulinum toxin treatment is a key success factor in aesthetic procedures and is governed by the… Expand
2008
2008
Background: Botulinum toxin type B (BoNT/B) reduces saliva production, suggesting it may be useful for the treatment of… Expand
2007
2007
Botulinum toxin is a neurotoxin produced by the Gram-positive, rod-shaped anaerobic bacterium Clostridium botulinum (1). First… Expand
Review
2006
Review
2006
Injections of botulinum toxin have revolutionised the treatment of focal spasticity. Before their advent, the medical treatment… Expand
2001
2001
Botulinum toxin type B (BoNT-B; Myobloc™) is a new botulinum toxin with demonstrated efficacy in patients with cervical dystonia… Expand
2001
2001
Neck pain occurs in a majority of patients with cervical dystonia. The cause of pain is unknown but may be attributable to the… Expand